BioMarin Pharmaceutical Statistics
Total Valuation
BMRN has a market cap or net worth of $11.88 billion. The enterprise value is $15.19 billion.
| Market Cap | 11.88B |
| Enterprise Value | 15.19B |
Important Dates
The last earnings date was Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BMRN has 193.28 million shares outstanding. The number of shares has increased by 0.61% in one year.
| Current Share Class | 193.28M |
| Shares Outstanding | 193.28M |
| Shares Change (YoY) | +0.61% |
| Shares Change (QoQ) | -1.62% |
| Owned by Insiders (%) | 0.53% |
| Owned by Institutions (%) | 100.30% |
| Float | 192.09M |
Valuation Ratios
The trailing PE ratio is 162.17 and the forward PE ratio is 10.01. BMRN's PEG ratio is 0.34.
| PE Ratio | 162.17 |
| Forward PE | 10.01 |
| PS Ratio | 3.49 |
| Forward PS | 2.86 |
| PB Ratio | 1.88 |
| P/TBV Ratio | 15.10 |
| P/FCF Ratio | 16.09 |
| P/OCF Ratio | 13.86 |
| PEG Ratio | 0.34 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 50.26, with an EV/FCF ratio of 20.58.
| EV / Earnings | 208.18 |
| EV / Sales | 4.46 |
| EV / EBITDA | 50.26 |
| EV / EBIT | 101.78 |
| EV / FCF | 20.58 |
Financial Position
The company has a current ratio of 2.39, with a Debt / Equity ratio of 0.66.
| Current Ratio | 2.39 |
| Quick Ratio | 1.16 |
| Debt / Equity | 0.66 |
| Debt / EBITDA | 13.85 |
| Debt / FCF | 5.67 |
| Interest Coverage | 1.79 |
Financial Efficiency
Return on equity (ROE) is 1.18% and return on invested capital (ROIC) is 2.54%.
| Return on Equity (ROE) | 1.18% |
| Return on Assets (ROA) | 2.55% |
| Return on Invested Capital (ROIC) | 2.54% |
| Return on Capital Employed (ROCE) | 1.48% |
| Weighted Average Cost of Capital (WACC) | 4.32% |
| Revenue Per Employee | $1.06M |
| Profits Per Employee | $22,655 |
| Employee Count | 3,221 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 1.04 |
Taxes
In the past 12 months, BMRN has paid $76.14 million in taxes.
| Income Tax | 76.14M |
| Effective Tax Rate | 51.06% |
Stock Price Statistics
The stock price has decreased by -0.76% in the last 52 weeks. The beta is 0.23, so BMRN's price volatility has been lower than the market average.
| Beta (5Y) | 0.23 |
| 52-Week Price Change | -0.76% |
| 50-Day Moving Average | 57.89 |
| 200-Day Moving Average | 56.44 |
| Relative Strength Index (RSI) | 60.31 |
| Average Volume (20 Days) | 1,707,400 |
Short Selling Information
The latest short interest is 14.32 million, so 7.41% of the outstanding shares have been sold short.
| Short Interest | 14.32M |
| Short Previous Month | 13.91M |
| Short % of Shares Out | 7.41% |
| Short % of Float | 7.45% |
| Short Ratio (days to cover) | 7.70 |
Income Statement
In the last 12 months, BMRN had revenue of $3.41 billion and earned $72.97 million in profits. Earnings per share was $0.38.
| Revenue | 3.41B |
| Gross Profit | 1.79B |
| Operating Income | 390.51M |
| Pretax Income | 149.11M |
| Net Income | 72.97M |
| EBITDA | 302.23M |
| EBIT | 149.26M |
| Earnings Per Share (EPS) | $0.38 |
Balance Sheet
The company has $874.01 million in cash and $4.19 billion in debt, with a net cash position of -$3.31 billion or -$17.14 per share.
| Cash & Cash Equivalents | 874.01M |
| Total Debt | 4.19B |
| Net Cash | -3.31B |
| Net Cash Per Share | -$17.14 |
| Equity (Book Value) | 6.32B |
| Book Value Per Share | 32.66 |
| Working Capital | 2.31B |
Cash Flow
In the last 12 months, operating cash flow was $857.09 million and capital expenditures -$118.91 million, giving a free cash flow of $738.18 million.
| Operating Cash Flow | 857.09M |
| Capital Expenditures | -118.91M |
| Depreciation & Amortization | 145.57M |
| Net Borrowing | 3.65B |
| Free Cash Flow | 738.18M |
| FCF Per Share | $3.82 |
Margins
Gross margin is 52.55%, with operating and profit margins of 11.46% and 2.14%.
| Gross Margin | 52.55% |
| Operating Margin | 11.46% |
| Pretax Margin | 4.38% |
| Profit Margin | 2.14% |
| EBITDA Margin | 8.87% |
| EBIT Margin | 4.38% |
| FCF Margin | 21.67% |
Dividends & Yields
BMRN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.61% |
| Shareholder Yield | -0.61% |
| Earnings Yield | 0.61% |
| FCF Yield | 6.21% |
Analyst Forecast
The average price target for BMRN is $88.16, which is 43.05% higher than the current price. The consensus rating is "Buy".
| Price Target | $88.16 |
| Price Target Difference | 43.05% |
| Analyst Consensus | Buy |
| Analyst Count | 25 |
| Revenue Growth Forecast (3Y) | 14.13% |
| EPS Growth Forecast (3Y) | 33.12% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |